{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:07:13Z","timestamp":1787612833400,"version":"build-2736575974"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":215,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["smoa.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Intracavernosal injection therapy (ICI) is an effective intervention used to treat erectile dysfunction (ED). It has been proposed that caution should be exercised when prescribing ICI to patients currently taking anticoagulants (AC) due to the theoretical increased risk of bleeding, however, there is limited literature describing complication rates of actively anticoagulated patients utilizing ICI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>We sought to determine whether there was a difference in bleeding and other complications in a cohort of patients using ICI therapy with or without concurrent AC use.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We reviewed our institutional electronic health record and identified 168 patients who were seen in our clinic from January to August 2020 who had either currently or previously utilized ICI therapy for ED treatment. These patients were surveyed regarding their ICI therapy as well as given the erectile dysfunction inventory for treatment satisfaction questionnaire. Data from 85 patients was obtained; 43 concurrently using AC during ICI therapy and 42 with no AC use. Fisher's exact test for categorical variables and a 2-tailed t-test were used with P &amp;lt; .05 considered to be significant.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Outcome<\/jats:title>\n                  <jats:p>Documented bleeding events (eg, bruising, hematoma), complications, and mean erectile dysfunction inventory for treatment satisfaction scores were compared between the 2 groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>There were more absolute bleeding complications in the AC group vs the no AC group, with 3 of 43 AC patients (7%, 95% confidence interval: 2.4\u201318.6) and 0\/42 no AC patients (0%, 95% confidence interval: 0\u20138.4) experiencing some type of bleeding complication on ICI. However, there was no statistically significant difference found in overall or stratified documented bleeding events and complications between the 2 groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Implications<\/jats:title>\n                  <jats:p>Patients with concurrent AC usage on ICI therapy reported a higher rate of absolute bleeding complications than our non-AC group.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Strengths and Limitations<\/jats:title>\n                  <jats:p>The strength of this study is addressing question of safety of ICI therapy in patients with concurrent AC usage. Limitations include single-center retrospective study design and underpowered sample size limiting confidence with which conclusions from data should guide future patient counseling regarding ICI risks.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Findings from a single-center cohort of patients suggest that ICI therapy may be a safe and effective treatment modality for ED in patients with concurrent anticoagulant usage, however, given the higher rate of absolute bleeding events in our AC cohort, future assessment in a higher-powered study is warranted in determining a more accurate estimation of risk or propensity for bleeding complications in patients on AC using ICI therapy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1016\/j.esxm.2022.100535","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T17:44:31Z","timestamp":1654278271000},"page":"100535-100535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Complication Rates in Patients Using Intracavernosal Injection Therapy for Erectile Dysfunction With or Without Concurrent Anticoagulant Use\u2014A Single-Center, Retrospective Pilot Study"],"prefix":"10.1093","volume":"10","author":[{"given":"Kyle A.","family":"Blum","sequence":"first","affiliation":[{"name":"Department of Surgery \u00a0 \u00a0 , Houston, TX , USA"},{"name":"Division of Urology \u00a0 \u00a0 , Houston, TX , USA"},{"name":"University of Texas McGovern Medical School, \u00a0 \u00a0 , Houston, TX , USA"},{"name":"Department of Urology \u00a0 , Houston, TX , USA"},{"name":"MD Anderson Cancer Center \u00a0 , Houston, TX , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin P.","family":"Mehr","sequence":"additional","affiliation":[{"name":"Department of Surgery \u00a0 \u00a0 , Houston, TX , USA"},{"name":"Division of Urology \u00a0 \u00a0 , Houston, TX , USA"},{"name":"University of Texas McGovern Medical School, \u00a0 \u00a0 , Houston, TX , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Green","sequence":"additional","affiliation":[{"name":"Department of Surgery \u00a0 \u00a0 , Houston, TX , USA"},{"name":"Division of Urology \u00a0 \u00a0 , Houston, TX , USA"},{"name":"University of Texas McGovern Medical School, \u00a0 \u00a0 , Houston, TX , USA"},{"name":"Department of Urology \u00a0 , Houston, TX , USA"},{"name":"MD Anderson Cancer Center \u00a0 , Houston, TX , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Conroy","sequence":"additional","affiliation":[{"name":"Department of Surgery \u00a0 \u00a0 , Houston, TX , USA"},{"name":"Division of Urology \u00a0 \u00a0 , Houston, TX , USA"},{"name":"University of Texas McGovern Medical School, \u00a0 \u00a0 , Houston, TX , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Marino","sequence":"additional","affiliation":[{"name":"Department of Surgery \u00a0 \u00a0 , Houston, TX , USA"},{"name":"Division of Urology \u00a0 \u00a0 , Houston, TX , USA"},{"name":"University of Texas McGovern Medical School, \u00a0 \u00a0 , Houston, TX , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Surgery \u00a0 \u00a0 , Houston, TX , USA"},{"name":"Division of Urology \u00a0 \u00a0 , Houston, TX , USA"},{"name":"University of Texas McGovern Medical School, \u00a0 \u00a0 , Houston, TX , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailash","family":"Panchapakesan","sequence":"additional","affiliation":[{"name":"Department of Surgery \u00a0 \u00a0 , Houston, TX , USA"},{"name":"Division of Urology \u00a0 \u00a0 , Houston, TX , USA"},{"name":"University of Texas McGovern Medical School, \u00a0 \u00a0 , Houston, TX , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Murphy","sequence":"additional","affiliation":[{"name":"Department of Surgery \u00a0 \u00a0 , Houston, TX , USA"},{"name":"Division of Urology \u00a0 \u00a0 , Houston, TX , USA"},{"name":"University of Texas McGovern Medical School, \u00a0 \u00a0 , Houston, TX , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sravan","family":"Panuganti","sequence":"additional","affiliation":[{"name":"Carolina Urology Partners , Gastonia, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Run","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Surgery \u00a0 \u00a0 , Houston, TX , USA"},{"name":"Division of Urology \u00a0 \u00a0 , Houston, TX , USA"},{"name":"University of Texas McGovern Medical School, \u00a0 \u00a0 , Houston, TX , USA"},{"name":"Department of Urology \u00a0 , Houston, TX , USA"},{"name":"MD Anderson Cancer Center \u00a0 , Houston, TX , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,3]]},"reference":[{"key":"2023012008495555600_bib0001","article-title":"A review of current and emerging therapeutic options for erectile dysfunction","volume":"7","author":"Chung","year":"2019","journal-title":"Med Sci (Basel)"},{"key":"2023012008495555600_bib0002","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41443-019-0186-z","article-title":"Long-term intracavernosal injection therapy: Treatment efficacy and patient satisfaction","volume":"32","author":"Bearelly","year":"2020","journal-title":"Int J Impot Res"},{"key":"2023012008495555600_bib0003","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ijir.2016.14","article-title":"What is the current role of intracavernosal injection in management of erectile dysfunction?","volume":"28","author":"El-Sakka","year":"2016","journal-title":"Int J Impot Res"},{"key":"2023012008495555600_bib0004","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.juro.2018.05.004","article-title":"Erectile dysfunction: AUA guideline","volume":"200","author":"Burnett","year":"2018","journal-title":"J Urol"},{"key":"2023012008495555600_bib0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/smrj.35","article-title":"Intracavernosal injection for the diagnosis, evaluation, and treatment of erectile dysfunction: A review","volume":"3","author":"Belew","year":"2015","journal-title":"Sex Med Rev"},{"issue":"Suppl. 1","key":"2023012008495555600_bib0006","doi-asserted-by":"crossref","first-page":"s59","DOI":"10.1185\/0300799009117041","article-title":"Erectile dysfunction: Intracavernous treatment","volume":"16","author":"Ledda","year":"2000","journal-title":"Curr Med Res Opin"},{"key":"2023012008495555600_bib0007","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000281308","article-title":"Diagnosis and therapy of erectile dysfunction using papaverine and phentolamine","volume":"43","author":"Zentgraf","year":"1988","journal-title":"Urol Int"},{"key":"2023012008495555600_bib0008","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41443-018-0046-2","article-title":"Combination therapy for erectile dysfunction involving a PDE5 inhibitor and alprostadil","volume":"30","author":"Moncada","year":"2018","journal-title":"Int J Impot Res"},{"key":"2023012008495555600_bib0009","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/sj.ijir.3901313","article-title":"A prospective randomized study to optimize the dosage of trimix ingredients and compare its efficacy and safety with prostaglandin E1","volume":"17","author":"Seyam","year":"2005","journal-title":"Int J Impot Res"},{"key":"2023012008495555600_bib0010","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00345-019-02727-5","article-title":"Erectile dysfunction: A global review of intracavernosal injectables","volume":"37","author":"Duncan","year":"2019","journal-title":"World J Urol"},{"key":"2023012008495555600_bib0011","author":"Pfizer Inc. Caverject (Alprostadil Injection) [package insert].U.S. Food and Drug Administration","year":"2017"},{"key":"2023012008495555600_bib0012","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0094-0143(05)70054-9","article-title":"Evaluation and nonsurgical management of erectile dysfunction","volume":"25","author":"Sharlip","year":"1998","journal-title":"Urol Clin North Am"},{"key":"2023012008495555600_bib0013","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0022-5347(01)66241-4","article-title":"Minimally invasive therapies in the treatment of erectile dysfunction in anticoagulated cases: a study of satisfaction and safety","volume":"155","author":"Limoge","year":"1996","journal-title":"J Urol"},{"key":"2023012008495555600_bib0014","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/sj.ijir.3900307","article-title":"Drop-out reasons and complications in self-injection therapy with a triple vasoactive drug mixture in sexual erectile dysfunction","volume":"10","author":"Casab\u00e9","year":"1998","journal-title":"Int J Impot Res"},{"key":"2023012008495555600_bib0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.ijir.3900377","article-title":"Intracavernous self-injection of prostaglandin E1 in the treatment of erectile dysfunction","volume":"11","author":"Kunelius","year":"1999","journal-title":"Int J Impot Res"},{"key":"2023012008495555600_bib0016","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000020277","article-title":"Safety and efficacy of alprostadil sterile powder (S. Po., CAVERJECT) in diabetic patients with erectile dysfunction","volume":"38","author":"Tsai","year":"2000","journal-title":"Eur Urol"},{"key":"2023012008495555600_bib0017","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0022-5347(01)66574-1","article-title":"Penile scarring with intracavernous injection therapy using prostaglandin E1: A risk factor analysis","volume":"155","author":"Chen","year":"1996","journal-title":"J Urol"},{"key":"2023012008495555600_bib0018","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/sj.ijir.3900951","article-title":"Clinical course of penile fibrosis in intracavernosal prostaglandin E1 injection therapy: A follow-up of 44 patients","volume":"15","author":"Chew","year":"2003","journal-title":"Int J Impot Res"},{"key":"2023012008495555600_bib0019","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1439-0272.2010.01091.x","article-title":"Long-term efficacy and safety of self-intracavernous injection of prostaglandin E1 for treatment of erectile dysfunction in China","volume":"43","author":"He","year":"2011","journal-title":"Andrologia"},{"key":"2023012008495555600_bib0020","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0090-4295(98)00582-2","article-title":"EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction","volume":"53","author":"Althof","year":"1999","journal-title":"Urology"},{"key":"2023012008495555600_bib0021","article-title":"Alprostadil, in StatPearls","author":"Jain","year":"2022"}],"container-title":["Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050116122000502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050116122000502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/smoa\/article-pdf\/10\/4\/100535\/48797725\/smoa_10_4_100535.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/smoa\/article-pdf\/10\/4\/100535\/48797725\/smoa_10_4_100535.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T09:22:34Z","timestamp":1674206554000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/smoa\/article\/10\/4\/100535\/6956747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,3]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.esxm.2022.100535","relation":{},"ISSN":["2050-1161"],"issn-type":[{"value":"2050-1161","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8]]},"published":{"date-parts":[[2022,6,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complication Rates in Patients Using Intracavernosal Injection Therapy for Erectile Dysfunction With or Without Concurrent Anticoagulant Use\u2014A Single-Center, Retrospective Pilot Study","name":"articletitle","label":"Article Title"},{"value":"Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esxm.2022.100535","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of the International Society for Sexual Medicine.","name":"copyright","label":"Copyright"}]}}